AE	adverse event
AGAT	arginine:glycine amidinotransferase
ADMA	asymmetric dimethylarginine
AF	atrial fibrillation
Arg	Arginine
CADASIL	Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
CAT	cationic amino acid transporters
CES	cardioembolic stroke
cGMP	cyclic guanosine monophosphate
CIMT	carotid intima media thickness
CKD	chronic kidney disease
CRP	C-reactive protein
CVD	cardiovascular disease
DDAH	dimethylarginine dimethylaminohydrolase
eNOS	endothelial nitric oxide synthase
EPC	endothelial progenitor cells
ESUS	embolic stroke of undetermined source
hArg	Homoarginine
HC	healthy controls
HIF	hypoxia inducible factor
HIS	Hachinsky Ischemic Score
HPLC-FL	high performance liquid chromatography and fluorescence detection
HR	hazard ratio
ICA	internal carotid artery
IL	interleukin
IS	ischemic stroke
iNOS	inducible nitric oxide synthase
LAA	large artery atherosclerosis
MACE	major cardiovascular outcome event
MCAO	middle cerebral artery occlusion
MCP-1	monocyte chemoattractant protein 1
MTHFR	methylenetetrahydrofolate reductase
mRS	modified Rankin scale
NIHSS	National Institutes of Health stroke scale
NMMA	monomethylarginine
nNOS	neuronal nitric oxide synthase
NO	nitric oxide
NOS	nitric oxide synthase
NR	not reported
n.s.	not significant
OR	odds ratio
PRMT	protein arginine methyltransferases
ROS	radical oxygen species
RA	rheumatoid arthritis
rtPA	recombinant tissue-type plasminogen activator
SD	standard deviation
SDMA	symmetric dimethylarginine
SVD	small vessel disease
TIA	transient ischemic attack
TNFα	tumor necrosis factor alpha